Fund details
Founded in 1987, Canaan is a long-established early-stage investor, currently investing from their 12th fund ($800M).
Go to profile
Partners related to this fund
Tim Shannon
General Partner
Tim uses his medical and business background to create value from early stage through FDA approval. He was previously a pulmonary physician and CEO of CuraGen, a biopharma company focused on oncology. He has an MD from the University of Connecticut and a BA in Chemistry from Amherst College.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Target regions
USA
Africa
Latin America
India
Asia-Pacific
Europe
Canada
Investment ranges
$1M - $3M
$3M - $10M
Focus areas
Biotech
Cybersecurity
Health
Enterprise
AI
Consumer
Fintech
Deeptech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
